the Effectiveness of Different Risk Scales In Predicting VTE in Respiratory Inpatients
Comparative Analysis of the Effectiveness of Different Risk Scales in Predicting Combined Venous Thrombophilia in Respiratory Inpatients
1 other identifier
observational
100
1 country
1
Brief Summary
To compare the predictive effectiveness of the Caprini risk assessment model, the Padua risk assessment model and the VTE risk assessment in medical patients mentioned in the 2018 edition of the Guidelines for the diagnosis, treatment and prevention of pulmonary thromboembolism on the risk of concomitant VTE in respiratory inpatients to provide a basis for clinical VTE assessment and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 29, 2021
CompletedFirst Posted
Study publicly available on registry
July 15, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedNovember 22, 2023
November 1, 2023
1.8 years
June 29, 2021
November 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VTE incidence
VTE incidence in patients with high risk of VTE
during hospitalization, an average of 2 weeks
Study Arms (1)
respiratory inpatient
respiratory inpatient with VTE
Interventions
Eligibility Criteria
From January 2015 to December 2020, inpatients in respiratory department, Third Hospital of Peking University
You may qualify if:
- age more than 18y respiratory inpatient
You may not qualify if:
- Patients with deep vein thrombosis or pulmonary thromboembolism, sequelae of deep vein thrombosis, and thrombosis in other parts of lower limbs were diagnosed; Patients with severe coagulation dysfunction or other hematological diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking UTH
Beijing, Beijing Municipality, 100191, China
Related Publications (1)
Luo XY, Zhang FX. [Validation of the Caprini risk assessment model for venous thromboembolism in Chinese hospitalized patients in a general hospital]. Zhonghua Yi Xue Za Zhi. 2017 Jun 27;97(24):1875-1877. doi: 10.3760/cma.j.issn.0376-2491.2017.24.007. Chinese.
PMID: 28648012BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jing Zhang, MD
Peking UTH
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2021
First Posted
July 15, 2021
Study Start
April 1, 2021
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
November 22, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share